Larimar Therapeutics Inc (LRMR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2019 | 09-2019 | 06-2019 | 03-2019 | 12-2018 | |
| Operating Expenses | -2,395 | 8,628 | 3,704 | 13,277 | 14,691 |
| Operating Income | 2,395 | -8,628 | -3,704 | -13,277 | -14,691 |
| Interest Expense | 0 | 0 | 0 | 500 | 499 |
| Other Income | -83 | 0 | 0 | 665 | 620 |
| Pre-tax Income | 2,312 | -8,628 | -3,704 | -13,112 | -14,570 |
| Net Income Continuous | 2,312 | -8,628 | -3,704 | -13,112 | -14,570 |
| Net Income | $2,312 | $-8,628 | $-3,704 | $-13,112 | $-14,570 |
| EPS Basic Total Ops | 2.43 | -1.42 | -0.61 | -4.20 | -4.08 |
| EPS Basic Continuous Ops | 2.45 | -1.42 | -0.61 | -4.22 | -4.09 |
| EPS Diluted Total Ops | 2.43 | -1.42 | -0.61 | -4.20 | -4.08 |
| EPS Diluted Continuous Ops | 2.45 | -1.42 | -0.61 | -4.22 | -4.09 |
| EBITDA(a) | $2,415 | $-8,608 | $-3,434 | $-13,509 | $-14,964 |